NOW PUBLISHED MONTHLY!
"Has shown the highest international standards and should be read by pharmacologists and clinical pharmacologists, as well as by practising psychiatrists, psychologists and doctors involved in the treatment of neurology and psychiatric disorders" - Graham D. Burrows, MD University of Melbourne, Australia
The Journal of Psychopharmacology is a fully peer-reviewed, international journal that publishes original research and review articles on preclinical and clinical aspects of psychopharmacology.The journal provides an essential forum for researchers and practising clinicians on the effects of drugs on animal and human behavior, and the mechanisms underlying these effects.
The Journal of Psychopharmacology is a fully peer-reviewed, international journal that publishes original research and review articles on preclinical and clinical aspects of psychopharmacology. The journal provides an essential forum for researchers and practicing clinicians on the effects of drugs on animal and human behavior, and the mechanisms underlying these effects.
The Journal of Psychopharmacology is truly international in scope and readership. This is reflected by its editorial board which has brought together the very best of clinical and preclinical psychopharmacology from around the world.
Published monthly, the Journal of Psychopharmacology provides readers with an extensive array of regular features, including:
Original Research - original scientific papers addressing preclinical and clinical aspects of psychopharmacology
Critique - papers on topics of general interest and importance written by experts, commentaries by other authorities and their rejoinders provide the reader with a rounded understanding of the issues involved
Perspectives - pithy, thought-provoking, short and focused reviews
Letters - facilitating an ongoing dialogue on key issues of psychopharmacology, the letters address issues raised by published articles, or report significant new findings that merit rapid dissemination
Sales support materials
Exhibit and meeting handouts
Direct mail inserts
Collections of articles on particular topics
Sponsored subscription opportunities
Advertising - Including conference listings and related events and launches
Discounts - For multiple orders and advance orders in a one year period
The Journal of Psychopharmacology provides an excellent international platform from which to present important clinical and pre-clinical research and an effective way to promote key products to your target audience in supplement or reprint formats.
The journal offers the full range of custom services to meet your individual printing requirements, including:
Journal Supplements - Rapidly produced (under 12 weeks from acceptance to delivery) and competitively priced, should you wish to sponsor an entire Supplement of new and original research material. All supplements are peer reviewed.
Reprints and author offprints - Including customized gloss laminate covers and full printing to requirements, saddle-stitched binding and standard shrink-wrapping at no additional cost. These can be used for:
This journal is a member of the Committee on Publication Ethics (COPE).
|Ian Anderson||Manchester University, UK|
|Theodora Duka||Sussex University, UK|
|Ian Goodver||University of Cambridge, UK|
|Andy Parrott||University of Wales, Swansea, UK|
|Barbara J Sahakian||Cambridge University, UK|
|Clare Stanford||University College London, UK|
|Peter S. Talbot||The University of Manchester, UK|
|Allan Young||McGill University, Canada|
|Katherine J Aitchison||University of Alberta, Canada|
|Giovanni Biggio||University of Cagliari, Italy|
|Jeffrey W Dalley||Cambridge University, UK|
|Simon J C Davies||CAMH, University of Toronto, Canada|
|Bill Deakin||University of Manchester, UK|
|Colin T Dourish||Oxford, UK|
|David P. Finn||National University of Ireland, Galway, Ireland|
|Guy Goodwin||University of Oxford, UK|
|Roland Griffiths||John Hopkins School of Medicine, Baltimore, USA|
|Catherine Harmer||University of Oxford, UK|
|David J Heal||RenaSci Consultancy Ltd, UK|
|Sean Hood||University of Western Australia, Perth, Australia|
|Marc Laruelle||UCB, Brussels, Belgium|
|Thelma Lovick||University of Bristol, UK|
|Mitul Mehta||King's College London, UK|
|Marcus Munafo||University of Bristol|
|Stefano Pallanti||University of Florence, Italy|
|Richard J Porter||New Zealand|
|Judy Pratt||University of Strathclyde, UK|
|Johannes G. Ramaekers||Maastricht University, Netherlands|
|Wim Reidel||Cambridge, UK|
|Emma SJ Robinson||University of Bristol, UK|
|Craig R. Rush||University of Kentucky, USA|
|David Taylor||University of London, UK|
|Joop M.A. van Gerven||CHDR, Leiden, Netherlands|
|Carlos A. Zarate Jr.||NIMH, Maryland, USA|
- Peer review policy
- Article types
2.1 Summary of manuscript structure/style
- How to submit your manuscript
- Journal contributor’s publishing agreement
4.1 SAGE Choice
- Declaration of conflicting interests policy
- Other conventions
6.1 Informed consent
7.1 Funding acknowledgement
- Manuscript style
9.1 File types
9.2 Journal style
9.3 Reference style
9.4 Manuscript preparation
9.4.1 Keywords and abstracts: Helping readers find your article online
9.4.2 Corresponding author contact details
9.4.3 Guidelines for submitting artwork, figures and other graphics
9.4.4Guidelines for submitting supplemental files
9.4.5 English language editing services
- After acceptance
10.2 E-Prints and complimentary copies
10.3 SAGE production
10.4 OnlineFirst publication
- Further information
The Journal of Psychopharmacology is a fully peer-reviewed, international journal that publishes original research and review articles on preclinical and clinical aspects of psychopharmacology. The journal provides an essential forum for researchers and practising clinicians on the effects of drugs on animal and human behavior, and the mechanisms underlying these effects.
"Has shown the highest international standards and should be read by pharmacologists and clinical pharmacologists, as well as by practising psychiatrists, psychologists and doctors involved in the treatment of neurology and psychiatric disorders"
- Graham D. Burrows, MD University of Melbourne, Australia
1. Peer review policy
The journal's policy is to obtain three (at least two) independent reviews of each article. It operates a single-blind reviewing policy in which the author and reviewer‟s names are mutually concealed – as such; submitted manuscripts should contain no identifying information.
Referees will be encouraged to provide substantive, constructive reviews that provide suggestions for improving the work and distinguish between mandatory and non-mandatory recommendations. All manuscripts accepted for publication are subject to editing for presentation, style and grammar. Any major redrafting is agreed with the author but the editor's decision on the text is final.
Review Articles. The Editors wish to encourage the following types of review, but request that authors contact them (email@example.com) in advance:
- General reviews; providing a synthesis of an area of psychopharmacology
- Perspectives; brief overviews, which are 4-6 printed pages in length including references, that address important new areas of general interest
- Critiques; focused and provocative reviews that are followed by a number of invited commentaries, with a concluding reply from the main author
Letters to the Editors. Readers' letters should address issues raised by published articles or should report significant new findings that merit rapid dissemination. The decision to publish is made by the Editors, in order to ensure a timely appearance in print.
Case reports will only be considered if they make a major impact on the field and generally need to reflect findings from more than a single case.
Journal no longer accepts book reviews. British Association for Psychopharmacology (BAP) publishes book reviews in their newsletter. Please contact Prof Brian E. Leonard, Emeritus Professor of Pharmacology, National University of Ireland, Galway (email:firstname.lastname@example.org).
2.1 Summary of manuscript structure
Journal of Psychopharmacology subscribes predominantly to the editorial preferences expressed in the Uniform Requirements for Manuscripts Submitted to Biomedical Journals issued by the International Committee of Medical Journal Editors.
Articles submitted for publication in Journal of Psychopharmacology should be typed and in double spacing throughout (this includes notes and references) and with generous margins all round. Each page should be identified with a shortened version of the title (Running title).
Elements within the Manuscript
Cover sheet. Preface your paper with a cover sheet that carries the title, authors' names, addresses and affiliations; plus email address, telephone number and fax number for the corresponding author. On this or the next following page list sources of support in the form of grants, equipment, drugs or all of these, and any disclaimers.
Key words, or key word phrases, to accompany the abstract should not exceed 10. They should, if possible, be drawn from the MeSH list of Index Medicus and be chosen with a view to useful cross-indexing of the article.
Abstract (200 words) of the article.
Text. Subdivide your article with appropriate headings. Use no more than three levels of subdivision. For observational and experimental articles the first level will usually consist of the standard heads: Introduction, Methods and Materials, Results and Discussion. Other types of articles will benefit from less formulaic formats.
Acknowledgements. Between the end of the text and the start of the References section, please acknowledge sources of financial and material support, and those who have contributed intellectually, with their consent.
References. Authors should be cited using the name and date convention, in date order: (Prewett and Green, 1989; Becker, 1992; Marlowe et al., 1994, Table 2). List authors up to two; for three or more use the name of the first author plus et al. References should have been checked against the original documents, and must be carefully cross-checked to ensure the text citation matches that in the reference list.
3. How to submit your manuscript
Before submitting your manuscript, please ensure you carefully read and adhere to all the guidelines and instructions to authors provided below. Manuscripts not conforming to these guidelines may be returned. If you would like to discuss your paper prior to submission, please contact the Editor at: email@example.com
Journal of Psychopharmacology has a fully web-based system for the submission and review of manuscripts. All submissions should be made online at the Journal of Psychopharmacology SAGETRACK website:
Note: Online submission and review of manuscripts is now mandatory for all types of papers.
New User Account
Please log onto the website. If you are a new user, you will first need to create an account. Follow the instructions and please ensure to enter a current and correct email address. Creating your account is a three-step process that takes a matter of minutes. When you have finished, your User ID and password is sent immediately via email. Please edit your user ID and password to something more memorable by selecting 'edit account' at the top of the screen. If you have already created an account but have forgotten your details type your email address in the 'Password Help' to receive an emailed reminder. Full instructions for uploading the manuscript are provided on the website.
Submissions should be made by logging in and selecting the Author Centre and the 'Click here to Submit a New Manuscript' option. Follow the instructions on each page, clicking the 'Next' button on each screen to save your work and advance to the next screen. If at any stage you have any questions or require the user guide, please use the 'Get Help Now' button at the top right of every screen. Further help is available through ScholarOne's® Manuscript CentralTM customer support at +1 434 817 2040 x 167 or email the editor with your manuscript as an attachment(s) and write a note to explain why you need to submit via this route.
To upload your files, click on the 'Browse' button and locate the file on your computer. Select the designation of each file (i.e. main document, submission form, figure) in the drop down menu next to the browse button. When you have selected all the files you wish to upload, click the 'Upload Files' button.
Review your submission (in both PDF and HTML formats) and then click the Submit button You may suspend a submission at any point before clicking the Submit button and save it to submit later. After submission, you will receive a confirmation e-mail. You can also log back into your author centre at any time to check the status of your manuscript.
Please ensure that you submit editable/source files only (Microsoft Word or RTF) and that your document does not include page numbers; the SAGETRACK system will generate them for you, and then automatically convert your manuscript to PDF for peer review. All correspondence, including notification of the Editor's decision and requests for revisions, will be by email.
If you would like to discuss your paper prior to submission contact the Editor:
If you seek advice on the submission process please contact the Publishing Editor:
4. Journal contributor’s publishing agreement
Before publication, SAGE requires the author as the rights holder to sign a Journal Contributor‟s Publishing Agreement. SAGE‟s Journal Contributor‟s Publishing Agreement is a exclusive licence agreement which means that the author retains copyright in the work but grants SAGE the sole and exclusive right and licence to publish for the full legal term of copyright. Exceptions may exist where an assignment of copyright is required or preferred by a proprietor other than SAGE. In this case copyright in the work will be assigned from the author to the society. For more information please visit our Frequently Asked Questions on the SAGE Journal Author Gateway.
4.1 SAGE Choice
If you wish your article to be freely available online immediately upon publication (as some funding bodies now require), you can opt for it to be included in SAGE Choice subject to payment of a publication fee. The manuscript submission and peer reviewing procedure is unchanged. On acceptance of your article, you will be asked to let SAGE know directly if you are choosing SAGE Choice. For further information, please visit SAGE Choice.
5. Declaration of conflicting interests
Within your Journal Contributor‟s Publishing Agreement you will be required to make a certification with respect to a declaration of conflicting interests. It is the policy of Journal of Psychopharmacology to require a declaration of conflicting interests from all authors enabling a statement to be carried within the paginated pages of all published articles.
Please include any declaration at the end of your manuscript after any acknowledgements and prior to the references, under a heading „Conflict of Interest Statement‟. If no declaration is made, the following will be printed under this heading in your article: „None Declared‟. Alternatively, you may wish to state that „The Author(s) declare(s) that there is no conflict of interest‟.
When making a declaration, the disclosure information must be specific and include any financial relationship that all authors of the article have with any sponsoring organization and the for-profit interests that the organisation represents, and with any for-profit product discussed or implied in the text of the article.
Any commercial or financial involvements that might represent an appearance of a conflict of interest need to be additionally disclosed in the covering letter accompanying your article to assist the Editor in evaluating whether sufficient disclosure has been made within the Conflict of Interest statement provided in the article.
For more information please visit the SAGE Journal Author Gateway.
6.1 Informed consent
Authors are required to ensure that the following guidelines are followed, as recommended by the International Committee of Medical Journal Editors ("Uniform Requirements for Manuscripts Submitted to Biomedical Journals": http://www.icmje.org/urm_full.pdf).
Patients have a right to privacy that should not be infringed without informed consent. Identifying information, including patients' names, initials, or hospital numbers, should not be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that a patient who is identifiable be shown the manuscript to be published.
Complete anonymity is difficult to achieve, however, and informed consent should be obtained if there is any doubt. For example, masking the eye region in photographs of patients is inadequate protection of anonymity. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note.
When informed consent has been obtained it should be indicated in the submitted article. Authors should identify individuals who provide writing/administrative assistance, indicate the extent of assistance and disclose the funding source for this assistance. Identifying details should be omitted if they are not essential.
When reporting experiments on human subjects, indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional or regional) or with the Declaration of Helsinki 1975, revised Hong Kong 1989. Do not use patients' names, initials or hospital numbers, especially in illustrative material. When reporting experiments on animals, indicate which guideline/law on the care and use of laboratory animals was followed.
All contributors who do not meet the criteria for authorship should be listed in an `Acknowledgements‟ section. Examples of those who might be acknowledged include a person who provided purely technical help, writing assistance, or a department chair who provided only general support. Authors should disclose whether they had any writing assistance and identify the entity that paid for this assistance.
7.1 Funding Acknowledgement
To comply with the guidance for Research Funders, Authors and Publishers issued by the Research Information Network (RIN), Journal of Psychopharmacology additionally requires all Authors to acknowledge their funding in a consistent fashion under a separate heading. All research articles should have a funding acknowledgement in the form of a sentence as follows, with the funding agency written out in full, followed by the grant number in square brackets:
This work was supported by the Medical Research Council [grant number xxx]. Multiple grant numbers should be separated by comma and space. Where the research was supported by more than one agency, the different agencies should be separated by semi- colons, with “and” before the final funder. Thus:
This work was supported by the Wellcome Trust [grant numbers xxxx, yyyy]; the Natural Environment Research Council [grant number zzzz]; and the Economic and Social Research Council [grant number aaaa].
In some cases, research is not funded by a specific project grant, but rather from the block grant and other resources available to a university, college or other research institution. Where no specific funding has been provided for the research we ask that corresponding authors use the following sentence:
This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
Please include this information under a separate heading entitled “Funding” directly after an y other Acknowledgements prior to your “Declaration of Conflicting Interests” (if applicable), any Notes and your References.
For more information on the guidance for Research Funders, Authors and Publishers, please visit: http://www.rin.ac.uk/funders-acknowledgement.
Authors are responsible for obtaining permission from copyright holders for reproducing any illustrations, tables, figures or lengthy quotations previously published elsewhere. For further information including guidance on fair dealing for criticism and review, please visit our Frequently Asked Questions on the SAGE Journal Author Gateway.
9.1 File types
Only electronic files conforming to the journal's guidelines will be accepted. Preferred formats for the text and tables of your manuscript are Word DOC, and tiff or jpeg for figures (ideally figures will use journal colours). Please also refer to additional guideline on submitting artwork [and supplemental files] below.
9.2 Journal Style
Journal of Psychopharmacology conforms to the SAGE house style. Click here to review guidelines on SAGE UK House Style, which is summarised in 2.1.
9.3 Reference Style
Journal of Psychopharmacology operates a SAGE Harvard reference style. Click here to review the guidelines on SAGE Harvard to ensure that your manuscript conforms to this reference style, which is summarised in 2.1.
Rickels K, Schweizer E, Clary C, Fox I, Weise C (1994) Nefazdone and imipramine in major depression: a placebo-controlled trial. Br J Psychiat 164: 802-805
Eysenck M W (1992) The nature of anxiety. In Gale A, Eysenck M W (eds), Handbook of individual differences: biological perspectives. John Wiley, Chichester
Maxwell S, Delaney H (1990) Designing experiments and analysing data: a model comparison perspective. Wadsworth, Belmont, CA
9.4.1 Keywords and Abstracts: Helping readers find your article online
The title, keywords and abstract are key to ensuring that readers find your article online through online search engines such as Google. Please refer to the information and guidance on how best to title your article, write your abstract and select your keywords by visiting SAGE‟s Journal Author Gateway Guidelines on How to Help
Readers Find Your Article Online.
9.4.2 Corresponding Author Contact details
Provide full contact details for the corresponding author including email, mailing address and telephone numbers. Academic affiliations are required for all co-authors.
9.4.3 Guidelines for submitting artwork, figures and other graphics
For guidance on the preparation of illustrations, pictures and graphs in electronic format, please visit SAGE‟s Manuscript Submission Guidelines.
Images should be supplied as bitmap based files (i.e. with .tiff or .jpeg extension) with a resolution of at least 300 dpi (dots per inch). Line art should be supplied as vector- based, separate .eps files (not as .tiff files, and not only inserted in the Word or pdf file), with a resolution of 600 dpi. Images should be clear, in focus, free of pixilation and not too light or dark.
If, together with your accepted article, you submit usable colour figures, these figures will appear in colour online regardless of whether or not these illustrations are reproduced in colour in the printed version. For specifically requested colour reproduction in print, you will receive information regarding the possible costs from SAGE after receipt of your accepted article.
Tables should be typed on separate sheets. They must all be cited in the text, carry brief but complete titles, and be numbered consecutively with Arabic numerals. Keep rules (horizontal only) to a minimum.
Figures should be used with discretion to clarify (not duplicate) the text. They should be cited in the text, using Arabic numerals, and their approximate location in the paper clearly indicated [Figure 1 near here]. They should, for preference, be supplied at reproduction size (single- or double-column width), and lettering should be no smaller than 8pt type. Computer-generated artwork must be submitted as laser printed output at a resolution of 600 dots per inch. Avoid the use of computer- generated tints; substitute hatching in their place. Photographs should be supplied as sharp black and white glossy prints, not laser output photos.
Figures (both photographs and artwork) should be identified lightly on a label attached to the back of the original, and clearly on a set of accompanying photocopies, with an arrow to indicate the top edge of the figure. Do not write directly on the back of any photograph or figure, do not attach paper clips or in any other way distort or scratch the image area. Photomicrographs should have internal scale markers; any symbols, arrows or letters used should be clearly visible against the background.
Legends should be explanatory but succinct. They should carry the Arabic numerals applicable to the figures, and be provided as a separate typed (double-spaced) list at the end of the paper, along with the figures themselves.
Units of measurement. Express these in SI and metric units; older conventional units may be added in parentheses. Nomenclature. Use the generic or chemical name of any drug, in lower case; the specific trade name (capitalized) may be given in parentheses after the first text reference.
Abbreviations and symbols. Use standard abbreviations, and define them in full in the first instance unless they are standard units of measurement. Avoid any use of abbreviations in the article title and abstract.
9.4.4 Guidelines for submitting supplemental files
The journal may be able to host approved supplemental materials online, alongside the full-text of articles. Supplemental files will be subjected to peer-review alongside the article. Please contact the editor (firstname.lastname@example.org) in the first instance. For more information please refer to SAGE‟s Guidelines for Authors on Supplemental Files.
9.4.5 English Language Editing services
Non-English speaking authors who would like to refine their use of language in their manuscripts might consider using a professional editing service. Visit http://www.sagepub.co.uk/authors/journal/submission.sp for further information.
We will email a PDF of the proofs to the corresponding author. Corrections should be limited to typographical amendments. Authors' approval will be assumed if corrections are not returned by the date indicated.
10.2 E-Prints and Complimentary Copies
SAGE provides authors with access to a PDF of their final article. For further information please visit http://www.sagepub.co.uk/authors/journal/reprint.sp. We additionally provide the corresponding author with complimentary copies of the print issue in which the article appears
- up to a maximum of 5 copies for onward supply by the corresponding author to co-authors.
10.3 SAGE Production
At SAGE we place an extremely strong emphasis on the highest production standards possible. We attach high importance to our quality service levels in copy-editing, typesetting, printing, and online publication (http://online.sagepub.com/). We also seek to uphold excellent author relations throughout the publication process.
We value your feedback to ensure that we continue to improve our author service levels. On publication all corresponding Authors will receive a brief survey questionnaire on your experience of publishing in Journal of Psychopharmacology with SAGE.
10.4 OnlineFirst Publication
Journal of Psychopharmacology provides the opportunity for your article to be included in
OnlineFirst, a feature offered through SAGE‟s electronic journal platform, SAGE Journals Online. It allows final revision articles (completed articles in queue for assignment to an upcoming issue) to be hosted online prior to their inclusion in a final print and online journal issue. This significantly reduces the lead time between submission and publication. For more information please visit our OnlineFirst Fact Sheet.
Dr Pallab Seth
Journal of Psychopharmacology Editorial office
Neuropsychopharmacology Unit Imperial College London Burlington-Danes Building Hammersmith Hospital
Du Cane Rd
London, W12 0NN
+44 (0) 207 594 6648